[Initial therapy of Hodgkin's disease using polychemotherapy. Long-term results of 204 cases (1-8 year follow-up)].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D004359:Drug Therapy, Combination; D001330:Electronic Data Processing; D005260:Female; D005500:Follow-Up Studies; D005602:France; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012075:Remission, Spontaneous; D012737:Sex Factors; D014750:Vincristine / Q000627:therapeutic use
D006834:Hydrazines; D009588:Nitrogen Mustard Compounds; D014750:Vincristine; D011241:Prednisone
Traitement initial de la maladie de Hodgkin par la polychimiothérapie. Résultats à long terme de 204 cas (1 à 8 ans de recul)